{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:04:53Z","timestamp":1780326293430,"version":"3.54.1"},"reference-count":36,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":151,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2026,5,2]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic peripheral neuropathy is a frequent and disabling complication of type 2 diabetes mellitus (T2DM). Early identification of subclinical neuropathy is crucial to prevent progression. F-wave parameters, by assessing proximal and distal motor pathways, may serve as sensitive indicators of early nerve dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate F-wave parameters in patients with T2DM and analyse their relationship with clinical neuropathy severity (Michigan Neuropathy Screening Instrument\u2014MNSI and Vibration Perception Threshold\u2014VPT) and metabolic control indices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This hospital-based cross-sectional study included 226 participants (184 diabetics and 42 non-diabetic controls). All subjects underwent detailed clinical evaluation, biochemical profiling, neuropathy assessment using MNSI and VPT, and electrophysiological testing including F-wave analysis of the tibial nerve. Parameters studied were F-min latency, F-max latency, chronodispersion, F-estimate, F-wave\/M-wave (F\/M) amplitude ratio and persistence. Comparisons were made among three groups\u2014non-diabetic controls, diabetics without neuropathy and diabetics with neuropathy. Correlation and receiver operating characteristic (ROC) analyses were performed to assess diagnostic and predictive utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>F-min, F-max and F-estimate latencies were significantly prolonged in diabetic subjects compared with controls (p&lt;0.001), with stepwise worsening from non-diabetic to neuropathic groups. Chronodispersion showed minor, non-significant change, and F\/M amplitude ratio exhibited mild elevation in diabetics (p&lt;0.05). F-wave persistence remained comparable across groups. Significant positive correlations were observed between F-min latency and VPT (r=0.424, p&lt;0.001), MNSI score (r=0.198, p=0.012) and glycated haemoglobin (HbA1c) (r=0.366, p=0.031). ROC analysis identified F-min latency (area under the curve, AUC=0.729) and F-max latency (AUC=0.710) as the most accurate discriminators for neuropathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Prolonged F-wave latencies, particularly minimum latency and F-estimate, are sensitive markers of early motor nerve involvement in T2DM. These parameters correlate with clinical and metabolic indices of neuropathy and can enhance detection of subclinical diabetic neuropathy when routine nerve conduction studies are normal.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjno-2025-001542","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:10:10Z","timestamp":1780323010000},"page":"e001542","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["F-minimum latency, F-maximum latency and F-estimate as early markers of neuropathy in type 2 diabetes mellitus: a cross-sectional study"],"prefix":"10.1136","volume":"8","author":[{"given":"Alpa Nasrin Samuel","family":"Shaikh","sequence":"first","affiliation":[{"name":"Physiology, All India Institute of Medical Sciences, Kalyani, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjusha Ashlesh","family":"Shinde","sequence":"additional","affiliation":[{"name":"Physiology, All India Institute of Medical Sciences, Kalyani, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubia","family":"Mondal","sequence":"additional","affiliation":[{"name":"Physiology, Presidency University, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Chakraborty","sequence":"additional","affiliation":[{"name":"Physiology, All India Institute of Medical Sciences, Kalyani, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1707-364X","authenticated-orcid":false,"given":"Tandra","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Physiology, All India Institute of Medical Sciences, Kalyani, West Bengal, India"},{"name":"AIIMS, Kalyani, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"2026060107100634000_8.1.e001542.1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0031-1271305","article-title":"The peripheral neuropathy evaluation in an office-based neurology setting","volume":"31","author":"Vavra","year":"2011","journal-title":"Semin Neurol"},{"key":"2026060107100634000_8.1.e001542.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16508-2"},{"key":"2026060107100634000_8.1.e001542.3","doi-asserted-by":"publisher","DOI":"10.1586\/eri.10.122"},{"key":"2026060107100634000_8.1.e001542.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2009.05.017"},{"key":"2026060107100634000_8.1.e001542.5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4103\/ijmr.IJMR_1087_14","article-title":"F wave index: A diagnostic tool for peripheral neuropathy","volume":"145","author":"Sathya","year":"2017","journal-title":"Indian J Med Res"},{"key":"2026060107100634000_8.1.e001542.6","unstructured":"Hilgevoord AJ , Visser O . F-wave. In: Aminoff HJ , Brown WF , Bolton CF , eds. Neuromuscular function and disease. 1st edn. Philadelphia: Saunders, 2002: 473\u201381."},{"key":"2026060107100634000_8.1.e001542.7","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.65.4.535"},{"key":"2026060107100634000_8.1.e001542.8","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880150808"},{"key":"2026060107100634000_8.1.e001542.9","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880151013"},{"key":"2026060107100634000_8.1.e001542.10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/mus.24127","article-title":"F-wave latencies in patients with diabetes mellitus","volume":"49","author":"Pan","year":"2014","journal-title":"Muscle Nerve"},{"key":"2026060107100634000_8.1.e001542.11","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199710)20:10<1296::AID-MUS12>3.0.CO;2-1"},{"key":"2026060107100634000_8.1.e001542.12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1600-0404.1987.tb07914.x","article-title":"Analysis of F-wave in metabolic neuropathies: a comparative study in uremic and diabetic patients","volume":"75","author":"Fierro","year":"1987","journal-title":"Acta Neurol Scand"},{"key":"2026060107100634000_8.1.e001542.13","first-page":"ii23","article-title":"Nerve conduction studies: essentials and pitfalls in practice","volume":"76 Suppl 2","author":"Mallik","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026060107100634000_8.1.e001542.14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4328\/ACAM.21495","article-title":"Comparison of nerve conduction studies and f-waves in the diagnosis of diabetic peripheral neuropathy","volume":"14","author":"Ya\u015far","year":"2023","journal-title":"Ann Clin Anal Med"},{"key":"2026060107100634000_8.1.e001542.15","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.17.11.1281"},{"key":"2026060107100634000_8.1.e001542.16","first-page":"LC20","article-title":"Vibration Perception Threshold Values and Clinical Symptoms of Diabetic Peripheral Neuropathy","volume":"12","author":"Medakkel","year":"2018","journal-title":"JCDR"},{"key":"2026060107100634000_8.1.e001542.17","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.4.956"},{"key":"2026060107100634000_8.1.e001542.18","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1303"},{"key":"2026060107100634000_8.1.e001542.19","unstructured":"Fisher MA , Chawla J , Webber CL . Deterministic recurrences of sequential F-wave latencies. Neurol Neurophysiol Neurosci 2006;8."},{"key":"2026060107100634000_8.1.e001542.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2004.07.017"},{"key":"2026060107100634000_8.1.e001542.21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.18071\/isz.75.0060","article-title":"Lower \/ upper extremity F-wave ratio for detecting early diabetic neuropathy","volume":"75","author":"\u00dcnl\u00fct\u00fcrk","year":"2022","journal-title":"Ideggyogy Sz"},{"key":"2026060107100634000_8.1.e001542.22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.34172\/mj.2021.030","article-title":"Comparison of diagnostic value of nerve conduction studies and F-wave in patients with diabetic polyneuropathy: a retrospective cross-sectional study","volume":"43","author":"Gorji","year":"2021","journal-title":"Med J"},{"key":"2026060107100634000_8.1.e001542.23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s41983-023-00718-3","article-title":"FM latency, FM ratio, F-wave latency versus F-wave index in the diagnosis of diabetic neuropathy","volume":"59","author":"Sathya","year":"2023","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"2026060107100634000_8.1.e001542.24","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.5455\/njppp.2018.8.0826828082018","article-title":"Nerve conduction study in neurologically asymptomatic diabetic patients and correlation with glycosylated hemoglobin and duration of diabetes","volume":"8","author":"Agarwal","year":"2018","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"2026060107100634000_8.1.e001542.25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4103\/ijnpnd.ijnpnd_18_23","article-title":"Nerve conduction parameters and its correlations with glycemic control and duration in type 2 diabetes mellitus \u2212 A cross-sectional study","volume":"13","author":"Shaji","year":"2023","journal-title":"Int J Nutr Pharmacol Neurol Dis"},{"key":"2026060107100634000_8.1.e001542.26","unstructured":"Preston DC , Shapiro BE . Electromyography and neuromuscular disorders. 2nd edn. Philadelphia: Elsevier, 2005:47\u201358."},{"key":"2026060107100634000_8.1.e001542.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neucli.2004.09.005"},{"key":"2026060107100634000_8.1.e001542.28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"41","year":"1991","journal-title":"Neurology (ECronicon)"},{"key":"2026060107100634000_8.1.e001542.29","doi-asserted-by":"publisher","DOI":"10.1016\/0924-980X(96)95635-0"},{"key":"2026060107100634000_8.1.e001542.30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/(SICI)1097-4598(199806)21:6<756::AID-MUS7>3.0.CO;2-6","article-title":"Nerve conduction velocities of single thenar motor axons based on the automated analysis of F waves in amyotrophic lateral sclerosis","volume":"21","author":"Felice","year":"1998","journal-title":"Muscle Nerve"},{"key":"2026060107100634000_8.1.e001542.31","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880020110"},{"key":"2026060107100634000_8.1.e001542.32","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(77)90211-8"},{"key":"2026060107100634000_8.1.e001542.33","doi-asserted-by":"publisher","DOI":"10.1016\/0168-5597(94)90027-2"},{"key":"2026060107100634000_8.1.e001542.34","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880140206"},{"key":"2026060107100634000_8.1.e001542.35","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880151102"},{"key":"2026060107100634000_8.1.e001542.36","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<344::AID-MUS5>3.0.CO;2-N"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2025-001542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:10:14Z","timestamp":1780323014000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2025-001542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6,1]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjno-2025-001542"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2025-001542","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}